EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Biofluid Biomarkers of Cognitive Functioning in Bipolar Disorder: A Systematic Review by the Targeting Cognition and Older‐Age Bipolar Disorder ISBD Task Forces

Alexandra J M Beunders iD, Sigfried N T M Schouws iD, Andrew T Olagunju iD, Vicent Balanzá-Martínez, Nicole C M Korten, Ralph W Kupka, Katherine E Burdick iD, Andre F Carvalho, Ariel G Gildengers, Lars V Kessing iD, Roger S McIntyre iD, Paula V Nunes und 10 weitere

Bipolar Disorders · 2026-08 · 28 (5)

DOI: 10.1111/bdi.70109 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Bipolar Disorders, online erschienen am 01.07.2026. Verfasst von Alexandra J M Beunders und 21 weiteren Autor:innen. Beteiligte Einrichtung: GGZ inGeest, Specialized Mental Health Care, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Bipolar Disorder, Biomarkers, Cognitive Dysfunction. Die Arbeit nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cognitive impairment is common in bipolar disorder (BD), but the underlying pathophysiology remains unclear. This systematic review aimed to (1) summarize all literature describing relationships of biofluid biomarkers and cognition in BD and (2) identify which biofluid biomarkers correlate most consistently with cognition in BD.

Methods

This systematic review followed procedures of the PRISMA statement. PubMed, EMBASE, and PsycINFO were searched from inception until July 2023. Original studies assessing the relationships between biofluid biomarkers and cognitive functioning in adults with BD were included. Studies on neuroimaging markers and genetic biomarkers were excluded.

Results

We identified 60 studies, together describing 184 biofluid biomarkers that were measured in relation to cognitive functioning in BD. Biomarkers were organized into ten categories: oxidative stress markers ( n = 14); growth factors ( n = 13); neurotransmitters ( n = 14); neuropeptides and hormones ( n = 14); neurodegenerative markers ( n = 11); inflammatory/immune markers ( n = 59); serostatus to infectious agents ( n = 11); amino acids, vitamins, and minerals ( n = 7); metabolic factors ( n = 23); hemogram, coagulation, and fibrinolysis markers ( n = 18). Preliminary evidence for a significant relationship with cognition appeared for HSV‐1 IgG, CRP, and homocysteine (Hcy); higher biomarker levels were associated with worse cognition.

Discussion

Included studies were heterogeneous and many were deemed to be of low quality following risk of bias assessment. The identified three biofluid biomarkers represent history of previous infections, current inflammation, and/or physical or psychological stress. Poor physical health, possibly represented by a broad range of biomarker aberrations, may play a role in the pathophysiology of cognitive impairment in BD. Trial Registration PROSPERO registration number: CRD42021224226

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bipolar DisorderBiomarkersCognitive DysfunctionHumans

Stichwörter der Autor:innen

biomarkerbipolar disordercognitioncognitive impairmentelderlyolder age bipolar disordersystematic review

Substanzen

Biomarkers

Autor:innen und Institutionen

  • GGZ inGeest, Specialized Mental Health Care, Amsterdam, the Netherlands.
  • Amsterdam Public Health Research Institute, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands.
  • Department of Psychiatry and Behavioural Neurosciences, McMaster University/St. Joseph's Healthcare, Hamilton, Ontario, Canada.
  • Department of Medicine, Universitat de València, Hospital Clínic Universitari de València, INCLIVA, CIBERSAM, Valencia, Spain.
  • Department of Medical Psychology, Northwest Clinics, Alkmaar, the Netherlands.
  • Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

ORCID-Profile: Alexandra J M Beunders, Sigfried N T M Schouws, Andrew T Olagunju, Katherine E Burdick, Lars V Kessing, Roger S McIntyre, Ayal Schaffer, Eduard Vieta, Annemiek Dols

Zitieren

APA

Beunders, A. J. M., Schouws, S. N. T. M., Olagunju, A. T., Balanzá-Martínez, V., Korten, N. C. M., Kupka, R. W., Burdick, K. E., Carvalho, A. F., Gildengers, A. G., Kessing, L. V., McIntyre, R. S., Nunes, P. V., Schaffer, A., Torres, I. J., Tsai, S. Y., Van Rheenen, T. E., Vieta, E., Yatham, L. N., Young, A. H., …, & Dols, A. (2026). Biofluid Biomarkers of Cognitive Functioning in Bipolar Disorder: A Systematic Review by the Targeting Cognition and Older‐Age Bipolar Disorder ISBD Task Forces. Bipolar Disorders, 28(5). https://doi.org/10.1111/bdi.70109

Vancouver

Beunders AJM, Schouws SNTM, Olagunju AT, Balanzá-Martínez V, Korten NCM, Kupka RW, et al. Biofluid Biomarkers of Cognitive Functioning in Bipolar Disorder: A Systematic Review by the Targeting Cognition and Older‐Age Bipolar Disorder ISBD Task Forces. Bipolar Disorders. 2026;28(5). doi:10.1111/bdi.70109

BibTeX
@article{Beunders2026,
  author = {Beunders, Alexandra J M and Schouws, Sigfried N T M and Olagunju, Andrew T and Balanzá-Martínez, Vicent and Korten, Nicole C M and Kupka, Ralph W and Burdick, Katherine E and Carvalho, Andre F and Gildengers, Ariel G and Kessing, Lars V and McIntyre, Roger S and Nunes, Paula V and Schaffer, Ayal and Torres, Ivan J and Tsai, Shang-Ying and Van Rheenen, Tamsyn E and Vieta, Eduard and Yatham, Lakshmi N and Young, Allan H and Eyler, Lisa T and Miskowiak, Kamilla W and Dols, Annemiek},
  title = {Biofluid Biomarkers of Cognitive Functioning in Bipolar Disorder: A Systematic Review by the Targeting Cognition and Older‐Age Bipolar Disorder ISBD Task Forces},
  journal = {Bipolar Disorders},
  year = {2026},
  volume = {28},
  number = {5},
  doi = {10.1111/bdi.70109}
}
Kostenlos starten →